Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Population dynamics of EMT elucidates the timing and distribution of phenotypic intra-tumoral heterogeneity. | iScience | 2023 | 37426354 | PubTator, text mining | PubMed |
| Erratum: CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1: Erratum. | Int J Biol Sci | 2023 | 37416782 | PubTator, text mining | PubMed |
| A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer. | Front Endocrinol (Lausanne) | 2023 | 37383389 | PubTator, text mining | PubMed |
| The Effects of a High-Fat Diet on Inflammatory Bowel Disease. | Biomolecules | 2023 | 37371485 | PubTator, text mining | PubMed |
| Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex. | Nat Commun | 2023 | 37353483 | PubTator, text mining | PubMed |
| Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma. | J Immunother Cancer | 2023 | 37349126 | PubTator, text mining | PubMed |
| Tissue-specific cancer stem/progenitor cells: Therapeutic implications. | World J Stem Cells | 2023 | 37342220 | PubTator, text mining | PubMed |
| Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity. | Cell Rep | 2023 | 37302069 | PubTator, text mining | PubMed |
| A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments. | Cancers (Basel) | 2023 | 37296850 | PubTator, text mining | PubMed |
| Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes. | Cell Rep Med | 2023 | 37290439 | PubTator, text mining | PubMed |
| Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma. | IET Syst Biol | 2023 | 37277696 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis uncovers intratumoral heterogeneity and drug-tolerant persister in ALK-rearranged lung adenocarcinoma. | Cancer Commun (Lond) | 2023 | 37272226 | PubTator, text mining | PubMed |
| Deterministic evolution and stringent selection during preneoplasia. | Nature | 2023 | 37258665 | PubTator, text mining | PubMed |
| Acute lymphoblastic leukemia relapse presenting with optic nerve infiltration. | SAGE Open Med Case Rep | 2023 | 37250823 | PubTator, text mining | PubMed |
| Tripartite motif-containing 9 promoted proliferation and migration of bladder cancer cells through CEACAM6-Smad2/3 axis. | J Cell Commun Signal | 2023 | 37249822 | PubTator, text mining | PubMed |
| Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen. | MAbs | 2023 | 37243574 | PubTator, text mining | PubMed |
| Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2023 | 37240110 | PubTator, text mining | PubMed |
| Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling. | Front Endocrinol (Lausanne) | 2023 | 37234801 | PubTator, text mining | PubMed |
| Glycomimetics for the inhibition and modulation of lectins. | Chem Soc Rev | 2023 | 37232696 | PubTator, text mining | PubMed |
| Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features. | Nat Commun | 2023 | 37225691 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers?page=13